TYMS and colorectal cancer: Notably, Castro-Rojas C. et al. reported that the TYMS rs45445694 polymorphism (5’VNTR 2R/2R) was associated with severe toxicity to the 5-FU-based chemotherapy in colorectal cancer patients.